Literature DB >> 7821139

Insulin omission in women with IDDM.

W H Polonsky1, B J Anderson, P A Lohrer, J E Aponte, A M Jacobson, C F Cole.   

Abstract

OBJECTIVE: To describe the extent of intentional insulin omission in an outpatient population of women with insulin-dependent diabetes mellitus (IDDM) and examine its relationship to disordered eating, attitudes toward diabetes, other psychosocial factors, long-term complications, and glycemic control. RESEARCH DESIGN AND METHODS: Before their routinely scheduled clinic appointments, female IDDM patients who were 13-60 years of age completed a self-report survey (final n = 341). The survey included standardized questionnaires assessing disordered eating attitudes and behaviors, psychological functioning (general distress, diabetes-specific distress, and hypoglycemic fear), attitudes toward diabetes, and self-care behaviors. All subjects were assessed for glycosylated hemoglobin within 30 days of survey completion. Long-term complications were determined through chart review.
RESULTS: Approximately 31% of the subject sample, representing women of all ages, reported intentional insulin omission, but only 8.8% reported frequent omission. Compared with non-omitters, omitters reported more disordered eating, greater psychological distress (general and diabetes-specific), more hypoglycemic fear, poorer regimen adherence, and greater fears concerning improved diabetes management (which may lead to weight gain). Omitters evidenced poorer glycemic control, more diabetes-related hospitalizations, and higher rates of retinopathy and neuropathy. Multivariate examination revealed only two variables that independently predicted omission: diabetes-specific distress and fear of improved glycemic control ("because I will gain weight"). Of the omitters, approximately half reported omitting insulin for weight-management purposes (weight-related omitters). These subjects evidenced significantly greater psychological distress, poorer regimen adherence (including more frequent omission), poorer glycemic control, and higher rates of complications than did non-weight-related omitters as well as non-omitters. Non-weight-related omitters tended to fall between weight-related omitters and non-omitters on most measures of psychological functioning, adherence, and glycemic control.
CONCLUSIONS: These findings suggest that insulin omission is common, that it is not limited to younger women, and that the medical consequences of omission, especially frequent omission, may be severe. Although a strong association between omission and disordered eating was observed, these data suggest that this link may be complicated by important diabetes-specific factors. Patients preoccupied with eating and weight concerns may also become emotionally overwhelmed by diabetes and/or fearful of normoglycemia (and the associated weight-related consequences), thus reinforcing the desire to omit insulin and maintain elevated blood glucose levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821139     DOI: 10.2337/diacare.17.10.1178

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  42 in total

Review 1.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

Review 2.  Risky business: risk behaviors in adolescents with type 1 diabetes.

Authors:  Sarah S Jaser; Heather Yates; Susan Dumser; Robin Whittemore
Journal:  Diabetes Educ       Date:  2011-10-14       Impact factor: 2.140

Review 3.  Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence.

Authors:  Israel Hartman
Journal:  Clin Med Res       Date:  2008-09-18

4.  Time of Day When Type 1 Diabetes Patients With Eating Disorder Symptoms Most Commonly Restrict Insulin.

Authors:  Rhonda M Merwin; Ashley A Moskovich; Lisa K Honeycutt; James D Lane; Mark Feinglos; Richard S Surwit; Nancy L Zucker; Natalia O Dmitrieva; Michael A Babyak; Heather Batchelder; Jan Mooney
Journal:  Psychosom Med       Date:  2018 Feb/Mar       Impact factor: 4.312

5.  Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.

Authors:  Meryl Brod; Paul Valensi; Joseph A Shaban; Don M Bushnell; Torsten L Christensen
Journal:  Qual Life Res       Date:  2010-07-04       Impact factor: 4.147

6.  Diabetes and eating disorders.

Authors:  Ann E Goebel-Fabbri
Journal:  J Diabetes Sci Technol       Date:  2008-05

Review 7.  Chronic illness and disordered eating: a discussion of the literature.

Authors:  Virginia M Quick; Carol Byrd-Bredbenner; Dianne Neumark-Sztainer
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

8.  Self-reported history of overweight and its relationship to disordered eating in adolescent girls with Type 1 diabetes.

Authors:  J T Markowitz; M R Lowe; L K Volkening; L M B Laffel
Journal:  Diabet Med       Date:  2009-11       Impact factor: 4.359

9.  Barriers to achieving glycemic targets: who omits insulin and why?

Authors:  Katie Weinger; Elizabeth A Beverly
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

10.  Brief screening tool for disordered eating in diabetes: internal consistency and external validity in a contemporary sample of pediatric patients with type 1 diabetes.

Authors:  Jessica T Markowitz; Deborah A Butler; Lisa K Volkening; Jeanne E Antisdel; Barbara J Anderson; Lori M B Laffel
Journal:  Diabetes Care       Date:  2009-12-23       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.